Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 45.00
Ask: 46.00
Change: -1.00 (-2.15%)
Spread: 1.00 (2.222%)
Open: 46.50
High: 45.50
Low: 45.00
Prev. Close: 46.50
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

Wed, 22nd Jul 2020 17:57

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Wednesday and not separately reported by Alliance News:

----------

Mears Group PLC - services provider to the UK's housing sector - Expects revenue from continuing activities in the first half to June 30 to fall 7.7% annually to GBP405 million from GBP439 million. Expects a pretax loss on continuing activities and before the amortisation of acquisition intangibles to be around GBP6.0 million, swinging from a GBP16.7 million profit. Expects a recovery in activity in second half, assuming Covid-19 infection levels remain low.

----------

Tristel PLC - Cambridgeshire-based manufacturer of infection prevention products - Results for year ended June 30 will be ahead of market expectations, with revenue coming in at GBP31.6 million, a 21% increase, and adjusted pretax profit rising at the same rate to GBP6.8 million. During the final four months of the year when Covid-19 impact was it its greatest, sales rose 30% annually.

----------

Barkby Group PLC - owner of businesses in real estate, consumer & hospitality and life sciences sectors - Withdraws forecast of Ebitda of GBP3.5 million for year ended June 30, due to Covid-19. Also secures GBP1 million loan under UK's coronavirus business interruption scheme. Notes Commercial Property Development completed construction of Hastings development in June. Hospitality arm made "positive" start to 2020 before Covid-19 interruption.

----------

Itaconix PLC - polymers maker - Expects revenue growth of 80% to USD1.1 million in six months to June 30. Notes several customers have boosted size of recurring orders due to increased demand amid Covid-19.

----------

Boku Inc - US-based mobile payments solution provider - Revenue for six months to June 30 expected to be at least USD24.7 million, a rise of 5.1% from USD23.5 million reported a year ago. Annual earnings before interest, tax, depreciation, and amortisation are expected in line with expectations and 65% higher from 2019.

----------

MobilityOne Ltd - e-commerce infrastructure payment solutions and platform provider - Says 50%-owned remittance firm OneTransfer Remittance Sdn Bhd signs money transfer agreement with MoneyGram Payment Systems Inc. Agreement means OTR customers can send money on MoneyGram platform.

----------

Blancco Technology Group PLC - data erasure firm with a sales office in Hertfordshire - Despite Covid-19 lengthening sales cycles, performance in year to June 30 was in line with market expectations with revenue inching 9.5% higher to GBP33.4 million from GBP30.5 million. Adjusted operating profit tipped to rise 14% to GBP4.0 million.

----------

Cloudcall Group PLC - cloud-based software firm with offices in Leicester, Sydney and Boston, US - Says revenue in six months to June 30 up 11% annually to GBP5.8 million. Recurring subscriptions up 20% to GBP5.1 million and users up 19% to 43,815.

----------

Quixant PLC - Cambridge-based technology outsourcer for gaming industry - Says key gaming unit sees "minimal" order over past three months as most clients closed due to Covid-19. The Densitron business unit however, has "experienced healthy demand from a range of industrial sectors".

----------

Empresaria Group PLC - West Sussex-based staffing firm - Profitable in both quarters during the six months ended June 30, despite Covid-19. Second quarter net fee income plunged 39% annually, contributing to a 22% fall in the whole of the first half to GBP28.2 million from GBP36.3 million. Made cost savings however, second quarter expenses were 30% lower year-on-year, after the first quarter when they fell 23%.

----------

Anexo Group PLC - Liverpool-based legal services provider - Trading continuing in line with expectations and plans to reinstate financial guidance for 2020 in its August interim report. Note some staff in its Bond Turner legal services division are returning to office working as Covid-19 lockdowns ease.

----------

Avacta Group PLC - Wetherby-based biotherapeutics firm - To begin clinical validation of Covid-19 laboratory test being developed by US-based Adeptrix as part of a UK government scheme.

----------

Resolute Mining Ltd - gold miner with assets in Senegal and Mali - Gold poured in quarter ended June down 3.2% to 107,183 ounces from 110,763 ounces in March. On track for 430,000 ounces poured in 2020.

----------

Alba Mineral Resources PLC - mineral exploration and development company with gold asset in Wales - Notes work activity as resumed at Clogau gold project, Wales following Covid-19 lockdown. Says priority for summer 2020 is completing underground bulk sampling programme, upon receipt of regulatory consent.

----------

Pure Gold Mining Inc Canada-based gold mine developer - Ontario Ministry of the Environment, Conservation & Parks approves and issues amended environmental compliance approval for air and noise emissions at Red Lake mine.

----------

Danakali Ltd - potash miner - Reports that notice of commencement of mine development at Colluli asset accepted by Eritrean Ministry of Energy & Mines.

----------

Predator Oil & Gas Holdings PLC - Jersey-based oil and gas company - Has made an offer to acquire Columbus Energy Resources PLC's stake in Inniss-Trinity CO2 project in Trinidad. Predator has option acquire interest for USD4.2 million but Predator's offer totalled USD1.8 million, so Columbus rejected.

----------

Jangada Mines PLC - natural resources company with vanadium asset in Brazil - reports "overwhelming success" from drilling campaign at its Pitombeiras vanadium project, Brazil. Received final five assay results received from the Goela target at project.

----------

Bluejay Mining PLC - explorer with assets in Greenland and Finland - Says agreement with "multinational commodity trading firm" at Dundas ilmenite project has increased. Offtake pact up 50% to between 250,000 and 300,000 tonnes per year, extending agreement by three months to October 31.

----------

Great Western Mining Corp PLC - mineral explorer with gold project in Nevada - Notes initial work has begun at the Trafalgar Hill, West Ridge and Rhyolite Dome targets at the Olympic Gold project in Nevada.

----------

Gunsynd PLC - London-based investment firm - Invests AUD200,000, about GBP110,000, in Eagle Mountain Mining Ltd, a copper and gold explorer. Forms part of Eagle Mountain's AUD3.0 million wider fundraising. The funds will finance a surface diamond drilling programme at its Oracle Ridge copper mine project.

----------

Dekel Agri-Vision PLC - West African focused agriculture company - Reports milling equipment for a cashew processing plant it is developing in Cote d'Ivoire has arrived at port of Abidjan from Italy as planned.

----------

Altus Strategies PLC - mining royalty firm - Reports preliminary economic assessment at Diba gold project, Mali. Reports a pretax net present value of USD115 million and a post-tax net present value of USD81 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2022 12:01

Avacta cancer drug candidate AVA6000 advances to fourth dose cohort

(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its fourth dose cohort.

Read more
21 Jul 2022 15:29

Avacta joint venture completes fresh funding round

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Thursday that AffyXell, its joint venture with Daewoong Pharmaceuticals, has completed a funding round to advance its lead mesenchymal stem cell (MSC) programme towards the clinic, and to develop its wider preclinical pipeline of cell therapies.

Read more
21 Jul 2022 12:17

Avacta joint venture completes funding for lead cell therapy programme

(Alliance News) - Avacta Group PLC on Thursday said that its joint venture AffyXell with Daewoong Pharmaceuticals Co Ltd has successfully completed a funding round.

Read more
30 Jun 2022 11:22

Avacta's partner LG Chem renews licence to develop Affimer platform

(Alliance News) - Avacta Group PLC said on Thursday that LG Chem Life Sciences has exercised its renewal option as part of an ongoing collaboration with the company, triggering a fee payment of USD2 million to Avacta.

Read more
29 Jun 2022 11:38

AIM WINNERS & LOSERS: Deltic rises on Shell deal; Windar down on delay

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
29 Jun 2022 10:21

Avacta shares up as cancer drug AVA6000 advances to third dose cohort

(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its third dose cohort after "a positive review of the safety data" from the second cohort.

Read more
16 Jun 2022 16:03

UK shareholder meetings calendar - next 7 days

Friday 17 June 
Blackstone Loan Financing LtdAGM
boohoo Group PLCAGM
Directa Plus PLCAGM
Tesco PLCAGM
EnQuest PLCAGM
Octopus Renewables Infrastructure Trust PLCAGM
Monday 20 June 
Armadale Capital PLCAGM
Bank of Georgia Group PLCAGM
Globalworth Real Estate Investments LtdAGM
MetalNRG PLCAGM
Midatech Pharma PLCAGM
Silver Bullet Data Services Group PLCGM re fundraise
Venture Life Group PLCAGM
Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Zinnwald Lithium PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 May 2022 14:04

IN BRIEF: Avacta joint venture expands partnership with GenScript

Avacta Group PLC - Cambridge, England-based drug developer and diagnostics company - Says its joint venture AffyXell with Seoul, South Korea-based drug maker Daewoong Pharmaceutical Co Ltd expanded its partnership with GenScript ProBio. Says the partnership covers the process development and production of viral vectors required for the production of AffyXell's future cell therapy products. Adds that GenScript has now committed to take an equity position in AffyXell at a future funding round. The two companies will also collaborate in the area of business development, including potential out-licensing.

Read more
13 Apr 2022 17:33

Avacta increases shareholding in drug developer AffyXell to 22%

(Alliance News) - Avacta Group PLC said on Wednesday it increased its shareholding in its South Korean joint venture, AffyXell Therapeutics.

Read more
13 Apr 2022 13:57

Avacta triggers milestone in Daewoong joint venture

(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Wednesday that a milestone equity payment has been triggered, resulting in an increase in its shareholding in AffyXell Therapeutics.

Read more
8 Apr 2022 16:17

Avacta joint venture enters new immune model collaboration

(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Friday that AffyXell Therapeutics - its joint venture with Daewoong Pharmaceutical - has entered into a collaboration agreement with Chinese biological drugs developer Biocytogen and the Korea Non-Clinical Technology Solution Center (KNTSC).

Read more
8 Apr 2022 11:28

AIM WINNERS & LOSERS: Sensyne Health drops amid AIM delisting warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
8 Apr 2022 10:37

Avacta joint venture to collaborate with Chinese biological company

(Alliance News) - Avacta Group PLC said on Friday its joint venture has found a Chinese collaborator to develop new biologic drugs.

Read more
6 Apr 2022 10:23

IN BRIEF: Avacta widens annual loss on research, manufacturing costs

Avacta Group PLC - Cambridge, England-based drug developer and diagnostics company - Posts widened loss in 2021. Pretax loss expands to GBP29.2 million from GBP18.9 million in 2020. However, revenue rises to GBP2.9 million from GBP2.1 million. Like the year before, there will be no dividends.

Read more
16 Mar 2022 13:02

Avacta offloads animal health unit in £2.3m deal

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that Vimian Group has acquired its veterinary division, Avacta Animal Health, for consideration of up to £2.3m.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.